SBK Financial’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-27
Closed -$5.39K – 336
2026
Q1
$5.39K Buy
+27
New +$5.34K ﹤0.01% 207

Other funds holding LGND

SBK Financial's LGND Position: Q2 2026 in Review

SBK Financial sold out of Ligand Pharmaceuticals (LGND) in Q2 2026, closing a stake of 27 shares — an estimated $5.39K sold.

SBK Financial first reported a position in LGND in Q1 2026 and held it in 1 quarter. The position peaked at $5.39K in Q1 2026. 419 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • SBK Financial reported no remaining Ligand Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • SBK Financial sold 27 Ligand Pharmaceuticals shares in Q2 2026, an estimated $5.39K.
  • SBK Financial first reported a position in Ligand Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • SBK Financial's Ligand Pharmaceuticals position peaked at $5.39K in Q1 2026.
  • 419 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on SBK Financial's 13F filing for Q2 2026, filed 2 Nov 2026.